Systemic manifestations in chronic obstructive pulmonary disease;Manifestações sistêmicas na doença pulmonar obstrutiva crônica

Jornal Brasileiro de Pneumologia

Volumn 32, Issue 2, 2006, Pages 161-171

  Dourado, Victor Zuniga ^a,c   Tanni, Suzana Erico ^b   Vale, Simone Alves ^b   Faganello, Márcia Maria ^b   Sanchez, Fernanda Figueirôa ^b   Godoy, Irma ^b  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Peixe Vivo   (Brazil)

Author keywords

Exercise tolerance; Neuromuscular manifestations; Nutritional status; Pulmonary disease, chronic obstructive complications

Indexed keywords

CYTOKINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE TOLERANCE; HUMAN; IMMUNOLOGY; INFLAMMATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NUTRITIONAL DISORDER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

CYTOKINES; EXERCISE TOLERANCE; HUMANS; INFLAMMATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NUTRITION DISORDERS; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33745498457     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132006000200012     Document Type: Review

References (71)

1. Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro sobre Tuberculose: Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol. 2004;30 Suppl 1:S1-S42.
2. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):26-33.
3. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574-80.
4. Comment in: Thorax. 2005;60(7):612-3; author reply 612-3.
5. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50-60.
6. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856-61.
7. Marquis K, Debigaré R, Lacasse Y, LéBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(6):809-13.
8. Comment in: Am J Respir Crit Care Med. 2002;166(6):787-9.
9. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12.
10. Comment in: ACP J Club. 2004;141(2):53;
11. N Engl J Med. 2004;350(10):965-6;
12. N Engl J Med. 2004;350(22):2308-10; author reply 2308-10.
13. World Health Organization. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated. Washington: National Institutes of Health and National Heart, Lung, and Blood Institute; 2004.
14. Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000;6(2):110-5.
15. Paiva SA, Godoy I, Vannucchi H, Favaro RM, Geraldo RR, Campana AO. Assessment of vitamin A status in chronic obstructive pulmonary disease patients and healthy smokers. Am J Clin Nutr. 1996;64(6):928-34.
16. Godoy I, Castro e Silva MH, Togashi RH, Geraldo RR, Campana AO. Is chronic hypoxemia in patients with chronic obstructive pulmonary disease associated with more marked nutritional deficiency? A study of fat-free-mass evaluated by anthropometry and bioelecritical impedance methods. J Nutr Health Aging. 2000;4(2):102-8.
17. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791-97.
18. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20(3):539-44.
19. Wouters, EF. Nutrition and metabolism in COPD. Chest. 2000;117(5 Suppl 1):274S-80S.
20. Ferreira I, Brooks D, Lacasse Y, Goldstein R. Nutrition intervention in COPD; a systematic overview. Chest. 2001;119(2):353-63.
21. Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med. 1996;153(2):633-7.
22. Creutzberg E. Leptin in relation to systemic inflammation and regulation of the energy balance. Eur Respir Mon 2003;24:56-67
23. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1179-84.
24. Neder JA, Nery LE, Cendon Filha SP, Ferreira IM, Jardim JR. Reabilitação pulmonar: fatores relacionados ao ganho aeróbio de pacientes com DPOC. J Pneumol. 1997;23(3):115-23.
25. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859-67.
26. Kessler R, Faller M, Fourgaut G, Mennecier B, Weintzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158-64.
27. Connors AF Jr, Dawson NV, Thomas C, Harrel FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study of Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959-67. Erratum in: Am J Respir Crit Care Med. 1997;155(1):386.
28. Mazolewski P, Turner JF, Baker M, Kurtz T, Little AG. The impact of nutritional status on the outcome of lung reduction surgery: a prospective study. Chest. 1999;116(3):693-6.
29. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003;123(5):1460-6.
30. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, n.2, 2005. Oxford: Update Software.
31. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl. 2003;46:81s-6s.
32. Storer TW. Exercise in chronic pulmonary disease: resistence exercise prescription. Med Sci Sports Exerc. 2001;33(7 Suppl):S680-6.
33. McArdle WD, Katch FI, Katch VL. Força muscular: treinando os músculos para se tornarem mais fortes In: McArdle WD, Katch FI, Katch VL, editors. Fisiologia do exercício: energia, nutrição e desempenho humano. 5a ed. Rio de Janeiro: Guanabara Koogan; 2001. p.513-61.
34. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A Statement of the American Thoracic Society and European. Am J Respir Crit Care Med. 1999; 159(4):S2-S40.
35. Cassart M, Pettiaux N, Gevenois PA, Paiva M, Estenne M. Effect of chronic hyperinflation on diaphragm length and surface area. Am J Respir Crit Care Med. 1997;156(2 Pt 1):504-8.
36. Orozco-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J. 2003;46:41s-51s.
37. Levine S, Nguyen T, Kaiser LR, Shrager JB. Evaluating respiratory muscle adaptations: a new approach. Am J Respir Crit Care Med. 2002;166(11):1418-9.
38. Comment in: Am J Respir Crit Care Med. 2002;166(11):1491-7.
39. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10(2):417-23.
40. Debigare R, Marquis K, Côté CH, Tremblay RR, Michaud A, LeBlanc P, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003;124(1):83-9.
41. Comment in: Chest. 2003;124(1):1-4.
42. Bernard S, LeBlanc P, Whitton F, Carrier G, Jobin J, Belleau R, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J Respir Crit Care Med. 1998;158(2):629-34.
43. Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2000;20(6):353-60.
44. Jagoe RT, Engelen MPKJ. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46: 52s-63s.
45. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998; 30(10):1467-74.
46. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153(1):288-93.
47. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Bélanger M, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000;55(10):848-53.
48. Allaire J, Maltais F, Doyon JF, Noel M, LeBlanc P, Carrier G, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004;59(8):673-8.
49. a ed. São Paulo: Manole; 2000. p.21-44.
50. Steiner MC, Morgan MD. Enhancing physical performance in chronic obstructive pulmonary disease. Thorax. 2001;56(1):73-7.
51. Pouw EM, Koerts-de Lang E, Gosker HR, Freling G, van der Vusse GJ, Wouters EF, et al. Muscle metabolic status in patients with severe COPD with and without longterm prednisolone. Eur Respir J. 2000;16(2):247-52.
52. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):939-45.
53. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable CPOD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151-6.
54. Yoneda T, Yoshikawa M, Fu A, Tsukaguchi K, Okamoto Y, Takenaka H. Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. Nutrition. 2001;17(2):95-9.
55. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 1997;138(10):4153-9.
56. de Martino M, Galli L, Chiarelli F, Verrotti A, Rossi ME, Bindi G, et al. Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection. Clin Immunol. 2000;94(3):212-8.
57. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106(5):506-12.
58. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am Respir Crit Care Med. 2003;167(12):1664-9.
59. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez de Suso JM, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(7):1114-8.
60. Comment in: Am J Respir Crit Care Med. 2001;164(7):1101-2;
61. Am J Respir Crit Care Med. 2002;165(9):1336-7; author reply 1337-8.
62. Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM. How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and to treat skeletal muscle dysfunction. Thorax. 2005;60(5):367-75.
63. Ambrosino N, Strambi S. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(2):313-22.
64. Neder JA. Estratégias emergentes para o recondicionamento muscular esquelético na DPOC. In: Terra Filho M, Fernandes ALG, Stirbulov R, editores. Pneumologia: atualização e reciclagem. São Paulo: Vivali; 2001. v.4, p.1-13.
65. Decramer M, Dekhuijzen PN, Troosters T, Van Herwaarden C, Rutten-Van Molken M, Van Schayck CP, et al. The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. Eur Respir J. 2001;17(3):329-36.
66. Berry JK, Baum C. Reversal of chronic obstructive pulmonary disease-associated weight loss: are there pharmacological treatment options? Drugs. 2004;64(10: 1041-52.
67. Sunyer J, Ulrik CS. Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effort beyond smoking and physical fitness? Eur Respir J. 2005;25(4):587-8.
68. Comment on: Eur Respir J. 2005;25(4):618-25.
69. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11): 1514-9.
70. Huiart L, Ernst P, Ranouil X, Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J. 2005;25(4):634-9.
71. Comment in: Eur Respir J. 2005;25(4):589-90.